Wipro, Godrej Properties and Hindustan Aeronautics to see some action today

Wipro has opened an Innovation Centre in Holborn, London. The company will invest euro 16 million over the next four years in the 20,000 sq. ft. Innovation Centre which will serve as Wipro’s flagship centre in the United Kingdom and offer technology expertise to companies in the UK and globally.

Godrej Properties’ sales bookings grew by 14 per cent to an all-time high of Rs 6,725 crore during the last financial year, despite a slowdown in the property market due to the pandemic. It has achieved sales bookings of more than Rs 1,300 crore each across its four major markets -- Delhi-NCR, Mumbai Metropolitan Region (MMR), Bengaluru and Pune. Godrej Properties is amongst India's largest developers by booking value. The residential segment contributed Rs 6,663 crore, while commercial projects Rs 62 crore in the overall sales bookings during the 2020-21 financial year.

Hindustan Aeronautics (HAL) and Rolls-Royce have signed Memorandum of Understanding (MoU) to establish packaging, installation, marketing and services support for Rolls-Royce MT30 marine engines in India. Through this MoU, Rolls-Royce and the company will expand their long-standing partnership in India and work together in the area of marine applications for the first time.

Bajaj Healthcare has launched ‘Favijaj’ (Favipiravir) an antiviral drug used for treating patients suffering from influenza virus and has proved to be effective over COVID patients. The company has received approval from India's drug regulator, to manufacture and market ‘Favijaj’ the oral Favipiravir approved medication in India for the treatment of COVID-19 from May 04, 2021.

Navneet Education has raised Rs 25 crore through Commercial Paper (CP) and allotted 500 units of Commercial Paper (CP) of Rs 5,00,000 each, at a discount rate of 3.68% p.a. Redemption Date of said Commercial Paper is July 19, 2021.

Satin Creditcare Network has received a senior loan facility of $5 million from Oesterreichische Entwicklungsbank - OeEB, Austria through External Commercial Borrowing channel. Earlier in November 2019, the company also signed a $15 million bilateral credit facility agreement with OeEB to finance income-generating and income-increasing activities of female small-scale and subsistence entrepreneurs in India.

Alembic Pharmaceuticals has reported results for fourth quarter March 31, 2021. The company has reported a fall of 26.47% in its net profit at Rs 231.11 crore for the quarter under review as compared to Rs 314.30 crore for the same quarter in the previous year. Total income of the company decreased by 1.55% at Rs 1161.27 crore for Q4FY21 as compared Rs 1179.57 crore for the corresponding quarter previous year. On the consolidated basis, the company has reported a rise of 11.61% in its net profit after taxes, non-controlling interests and share of profit of Associates and Joint Ventures at Rs 250.70 crore for the quarter under review as compared to Rs 224.63 crore for the same quarter in the previous year. Total income of the company increased by 6.34% at Rs 1284.34 crore for Q4FY21 as compared Rs 1207.72 crore for the corresponding quarter previous year.